This announcement is a separate document:
广东华商（长沙）律师事务所关于湖南方盛制药股份有限公司2022年限制性股票激励计划首次授予部分第二个解除限售期限制性股票解锁暨上市的法律意见书
Legal Opinion of Guangdong Huashang (Changsha) Law Firm on the unlocking of the first restricted stocks awarded under the Hunan Fangsheng Pharmaceutical Co., Ltd. 2022 Restricted Stock Incentive Plan and its listing.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.